产品说明
一般描述
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
生化/生理作用
一种强效生长抑制剂及细胞毒素剂，抑制 DNA 甲基转移酶，一种基因表达、基因激活和沉默的重要调节机制。
分析说明
These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
其他说明
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
附注
To see an example of a Certificate of Analysis for this material enter LRAB1224 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.
基本信息
| 经验(实验)分子式 | C8H12N4O5 |
| 分子量 | 244.20 |
| Beilstein | 620461 |
| EC 号 | 206-280-2 |
| MDL编号 | MFCD00006539 |
| NACRES | NA.24 |
产品性质
| 质量水平 | 300 |
| 等级 | certified reference material pharmaceutical secondary standard |
| 形式 | powder |
| CofA | current certificate can be downloaded |
| 包装 | pkg of 300 mg |
| mp | 226-232 ℃ (dec.) (lit.) |
| application(s) | pharmaceutical |
| 药典可追溯性 | traceable to USP 1045520 |
| 储存温度 | 2-8℃ |
| SMILES string | NC1=NC(=O)N(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O |
| InChI | 1S/C8H12N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h2-6,13-15H,1H2,(H2,9,11,16)/t3-,4-,5-,6-/m1/s1 |
| InChI key | NMUSYJAQQFHJEW-KVTDHHQDSA-N |
| Gene Information | human ... DNMT1(1786), DNMT3A(1788) |
安全信息
| 象形图 |    |
| 警示用语： | Danger |
| 危险声明 | H302 - H341 - H350 - H360FD - H372 - H410 |
| 预防措施声明 | P202 - P260 - P264 - P273 - P301 + P312 - P308 + P313 |
| 危险分类 | Acute Tox. 4 Oral - Aquatic Chronic 1 - Carc. 1A - Muta. 2 - Repr. 1B - STOT RE 1 |
| 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects |
| WGK | WGK 3 |
m.cnreagent.com
